Eligibility for icosapent ethyl 1–3 months after acute coronary syndrome and the risk for myocardial re-infarction: Data from the CALLINICUS-Hellas Registry

Loukianos S. Rallidis, Donatos Tsamoulis, Konstantinos A. Papathanasiou, Petros Kalogeras, Stylianos Daios, Vasilis Afentoulis, Nikolaos Makridakis, Christos Roussos, Ioannis Leventis, Athanasios Styliaras, Ilektra Stamou, Nikos Argyriou, Aristi Boulmpou, Vasileios Bouratzis, Andreas Ntalaoutis, Belkis Malkots, Niki Kakouri, Panagiotis Nastatos, Michalis Kyriazis, Sofia Xanthopoulou, Tsampika Gaitanaki, Charalambos Vlachopoulos

Open source

DOI: 10.1016/j.ijcard.2025.133684
Published: 2025-12
Container: International Journal of Cardiology
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ijcard.2025.133684,
  title = {Eligibility for icosapent ethyl 1–3 months after acute coronary syndrome and the risk for myocardial re-infarction: Data from the CALLINICUS-Hellas Registry},
  author = {Loukianos S. Rallidis and Donatos Tsamoulis and Konstantinos A. Papathanasiou and Petros Kalogeras and Stylianos Daios and Vasilis Afentoulis and Nikolaos Makridakis and Christos Roussos and Ioannis Leventis and Athanasios Styliaras and Ilektra Stamou and Nikos Argyriou and Aristi Boulmpou and Vasileios Bouratzis and Andreas Ntalaoutis and Belkis Malkots and Niki Kakouri and Panagiotis Nastatos and Michalis Kyriazis and Sofia Xanthopoulou and Tsampika Gaitanaki and Charalambos Vlachopoulos},
  year = {2025},
  journal = {International Journal of Cardiology},
  doi = {10.1016/j.ijcard.2025.133684},
  url = {https://doi.org/10.1016/j.ijcard.2025.133684}
}

RIS

TY  - JOUR
TI  - Eligibility for icosapent ethyl 1–3 months after acute coronary syndrome and the risk for myocardial re-infarction: Data from the CALLINICUS-Hellas Registry
AU  - Loukianos S. Rallidis
AU  - Donatos Tsamoulis
AU  - Konstantinos A. Papathanasiou
AU  - Petros Kalogeras
AU  - Stylianos Daios
AU  - Vasilis Afentoulis
AU  - Nikolaos Makridakis
AU  - Christos Roussos
AU  - Ioannis Leventis
AU  - Athanasios Styliaras
AU  - Ilektra Stamou
AU  - Nikos Argyriou
AU  - Aristi Boulmpou
AU  - Vasileios Bouratzis
AU  - Andreas Ntalaoutis
AU  - Belkis Malkots
AU  - Niki Kakouri
AU  - Panagiotis Nastatos
AU  - Michalis Kyriazis
AU  - Sofia Xanthopoulou
AU  - Tsampika Gaitanaki
AU  - Charalambos Vlachopoulos
PY  - 2025
JO  - International Journal of Cardiology
DO  - 10.1016/j.ijcard.2025.133684
UR  - https://doi.org/10.1016/j.ijcard.2025.133684
ER  -

APA

Rallidis, L. S., Tsamoulis, D., Papathanasiou, K. A., Kalogeras, P., Daios, S., Afentoulis, V., Makridakis, N., Roussos, C., Leventis, I., Styliaras, A., Stamou, I., Argyriou, N., Boulmpou, A., Bouratzis, V., Ntalaoutis, A., Malkots, B., Kakouri, N., Nastatos, P., Kyriazis, M., Xanthopoulou, S., Gaitanaki, T., & Vlachopoulos, C. (2025). Eligibility for icosapent ethyl 1–3 months after acute coronary syndrome and the risk for myocardial re-infarction: Data from the CALLINICUS-Hellas Registry. International Journal of Cardiology. https://doi.org/10.1016/j.ijcard.2025.133684

Source records

crossref · retrieved 2026-09-27T22:15:32.838Z